Cansinobio submitted its latest monthly report on securities changes to the Hong Kong Exchanges and Clearing Limited on September 3, 2024, reporting the changes in its shares as of August 31, 2024. The report shows that there were no increases or decreases in Cansinobio's H shares and A shares during the reporting period, with the number of H shares remaining at 132,670,900 and the number of A shares remaining at 114,778,999. In addition, as of August 31, 2024, the company has repurchased 406,098 ordinary shares of A shares under the A share repurchase plan approved by the board of directors on January 23, 2022, but no cancellation has been made. This repurchase plan is designed for future employee share ownership plans or stock-based incentive plans, and no new A share repurchases have been made during the period of August 2024.

Cansinobio submitted its latest monthly report on securities changes to the Hong Kong Exchanges and Clearing Limited on September 3, 2024, reporting the changes in its shares as of August 31, 2024. The report shows that there were no increases or decreases in Cansinobio's H shares and A shares during the reporting period, with the number of H shares remaining at 132,670,900 and the number of A shares remaining at 114,778,999. In addition, as of August 31, 2024, the company has repurchased 406,098 ordinary shares of A shares under the A share repurchase plan approved by the board of directors on January 23, 2022, but no cancellation has been made. This repurchase plan is designed for future employee share ownership plans or stock-based incentive plans, and no new A share repurchases have been made during the period of August 2024.